Apolipoprotein A1 potentiates lipoxin A4 synthesis and recovery of allergen-induced disrupted tight junctions in the airway epithelium

Clinical and Experimental Allergy

Volumn 43, Issue 8, 2013, Pages 914-927

  Park, S W ^a   Lee, E H ^a   Lee, E J ^a   Kim, H J ^a   Bae, D J ^a   Han, S ^b   Kim, D ^b   Jang, A S ^a   Uh, S T ^c   Kim, Y H ^c   Erle, D J ^d   Park, C S ^a  

^a Soonchunhyang University Bucheon Hospital   (South Korea)

^b Konkuk University   (South Korea)

^c Soonchunhyang University   (South Korea)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apolipoprotein A1; Asthma; Lipoxin A4; Lung; Tight junction

Indexed keywords

ALLERGEN; APOLIPOPROTEIN A1; INTERLEUKIN 25; INTERLEUKIN 33; LIPOXIN A; OCCLUDIN; PROTEIN ZO1; THYMIC STROMAL LYMPHOPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DERMATOPHAGOIDES; ELECTRIC RESISTANCE; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; TIGHT JUNCTION;

APOLIPOPROTEIN A1; ASTHMA; LIPOXIN A4; LUNG; TIGHT JUNCTION;

ALLERGENS; ANIMALS; APOLIPOPROTEIN A-I; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DENDRITIC CELLS; HUMANS; LIPOXINS; LUNG; MALE; MICE; PYROGLYPHIDAE; RESPIRATORY MUCOSA; TIGHT JUNCTIONS;

EID: 84880994782     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12143     Document Type: Article

References (62)

1. Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI/WHO workshop report. Bethesda, Md: National Institutes of Health National Heart, Lung, and blood Institute; 1995. NIH publication no. 95-3659.
2. Holgate ST, Davies DE, Powell RM, Howarth PH, Haitchi HM, Holloway JW. Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms. Eur Respir J 2007; 29:793-803.
3. Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med 2012; 18:684-92.
4. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008; 8:183-92.
5. Locksley RM. Asthma and allergic inflammation. Cell 2010; 140:777-83.
6. Fahy JV, Locksley RM. The airway epithelium as a regulator of th2 responses in asthma. Am J Respir Crit Care Med 2011; 184:390-2.
7. Dragsten PR, Blumenthal R, Handler JS. Membrane asymmetry in epithelia: is the tight junction a barrier to diffusion in the plasma membrane? Nature 1981; 294:718-22.
8. Cereijido M, Gonzalez-Mariscal L, Contreras RG. Epithelial tight junctions. Am Rev Respir Dis 1988; 138:S17-21.
9. Steed E, Balda MS, Matter K. Dynamics and functions of tight junctions. Trends Cell Biol 2010; 20:142-9.
10. Wan H, Winton HL, Soeller C et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999; 104: 123-33.
11. Evans SM, Blyth DI, Wong T, Sanjar S, West MR. Decreased distribution of lung epithelial junction proteins after intratracheal antigen or lipopolysaccharide challenge: correlation with neutrophil influx and levels of BALF sE-cadherin. Am J Respir Cell Mol Biol 2002; 27:446-54.
12. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007; 120:1233-44; quiz 1245-1236.
13. Xiao C, Puddicombe SM, Field S et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol 2011; 128:549-56 e541-512.
14. Knight D. Increased permeability of asthmatic epithelial cells to pollutants. Does this mean that they are intrinsically abnormal? Clin Exp Allergy 2002; 32:1263-5.
15. Barbato A, Turato G, Baraldo S et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med 2006; 174:975-81.
16. Taube C, Miyahara N, Ott V et al. The leukotriene B4 receptor (BLT1) is required for effector CD8 + T cell-mediated, mast cell-dependent airway hyperresponsiveness. J Immunol 2006; 176:3157-64.
17. Planaguma A, Kazani S, Marigowda G et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 2008; 178:574-82.
18. Plump AS, Scott CJ, Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 1994; 91:9607-11.
19. Sethi AA, Amar M, Shamburek RD, Remaley AT. Apolipoprotein AI mimetic peptides: possible new agents for the treatment of atherosclerosis. Curr Opin Investig Drugs 2007; 8:201-12.
20. Baker PW, Rye KA, Gamble JR, Vadas MA, Barter PJ. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J Lipid Res 1999; 40:345-53.
21. Navab M, Anantharamaiah GM, Fogelman AM. The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med 2005; 15:158-61.
22. Robbesyn F, Garcia V, Auge N et al. HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells. FASEB J 2003; 17:743-5.
23. Xia P, Vadas MA, Rye KA, Barter PJ, Gamble JR. High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL. J Biol Chem 1999; 274:33143-7.
24. Li Y, Dong JB, Wu MP. Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice. Eur J Pharmacol 2008; 590:417-22.
25. Shi N, Wu MP. Apolipoprotein A-I attenuates renal ischemia/reperfusion injury in rats. J Biomed Sci 2008; 15:577-83.
26. Amar MJ, D'Souza W, Turner S et al. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice. J Pharmacol Exp Ther 2010; 334:634-41.
27. Nandedkar SD, Weihrauch D, Xu H et al. D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma. J Lipid Res 2010; 52:499-508.
28. Wang W, Xu H, Shi Y et al. Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung. J Lipid Res 2010; 51:2560-70.
29. Yao X, Dai C, Fredriksson K et al. 5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthma. J Immunol 2010; 186:576-83.
30. Park CS, Lee SM, Uh ST et al. Soluble interleukin-2 receptor and cellular profiles in bronchoalveolar lavage fluid from patients with bronchial asthma. J Allergy Clin Immunol 1993; 91:623-33.
31. Workshop summary and guidelines. Investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. J Allergy Clin Immunol 1991; 88:808-14.
32. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009; 15:410-6.
33. Han JM, Jeong TS, Lee WS, Choi I, Cho KH. Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. J Lipid Res 2005; 46:589-96.
34. Choi JM, Ahn MH, Chae WJ et al. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat Med 2006; 12:574-9.
35. Idzko M, Hammad H, van Nimwegen M et al. Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest 2007; 117:464-72.
36. Angkasekwinai P, Park H, Wang YH et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204:1509-17.
37. Oboki K, Nakae S, Matsumoto K, Saito H. IL-33 and Airway Inflammation. Allergy Asthma Immunol Res 2011; 3:81-8.
38. Zhou B, Comeau MR, De Smedt T et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005; 6:1047-53.
39. Tillie-Leblond I, Gosset P, Le Berre R et al. Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats. Eur Respir J 2007; 30:31-9.
40. de Boer WI, Sharma HS, Baelemans SM, Hoogsteden HC, Lambrecht BN, Braunstahl GJ. Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. Can J Physiol Pharmacol 2008; 86:105-12.
41. Grumbach Y, Quynh NV, Chiron R, Urbach V. LXA4 stimulates ZO-1 expression and transepithelial electrical resistance in human airway epithelial (16HBE14o-) cells. Am J Physiol Lung Cell Mol Physiol 2009; 296:L101-8.
42. Komai-Koma M, Xu D, Li Y, McKenzie AN, McInnes IB, Liew FY. IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 2007; 37:2779-86.
43. Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23:479-90.
44. Kouzaki H, Iijima K, Kobayashi T, O'Grady SM, Kita H. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 2011; 186:4375-87.
45. Gregory LG, Mathie SA, Walker SA, Pegorier S, Jones CP, Lloyd CM. Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am J Respir Crit Care Med 2010; 182:143-54.
46. Yu HS, Angkasekwinai P, Chang SH, Chung Y, Dong C. Protease allergens induce the expression of IL-25 via Erk and p38 MAPK pathway. J Korean Med Sci 2010; 25:829-34.
47. Ziegler SF, Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010; 11:289-93.
48. Wan H, Winton HL, Soeller C et al. Quantitative structural and biochemical analyses of tight junction dynamics following exposure of epithelial cells to house dust mite allergen Der p 1. Clin Exp Allergy 2000; 30:685-98.
49. Balda MS, Matter K. Tight junctions. J Cell Sci 1998; 111(Pt 5):541-7.
50. Takata S, Matsubara M, Allen PG, Janmey PA, Serhan CN, Brady HR. Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium. J Clin Invest 1994; 93:499-508.
51. Wang Y, Liang D, Wang S et al. Role of the G-protein and tyrosine kinase-Rho/ROK pathways in 15-hydroxyeicosatetraenoic acid induced pulmonary vasoconstriction in hypoxic rats. J Biochem 2010; 147:751-64.
52. Bonnans C, Chanez P, Chavis C. Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation? Allergy 2004; 59:1027-41.
53. Levy BD, De Sanctis GT, Devchand PR et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 2002; 8:1018-23.
54. Dioszeghy V, Rosas M, Maskrey BH et al. 12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo. J Immunol 2008; 181:6514-24.
55. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987; 237:1171-6.
56. Aliberti J, Hieny S. Reis e Sousa C, Serhan CN, Sher A, Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol 2002; 3:76-82.
57. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 2000; 164:1663-7.
58. Mitchell S, Thomas G, Harvey K et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol 2002; 13:2497-507.
59. Dai C, Yao X, Keeran KJ et al. Apolipoprotein A-I attenuates ovalbumin-induced neutrophilic airway inflammation via a granulocyte colony-stimulating factor-dependent mechanism. Am J Respir Cell Mol Biol 2012; 47:186-95.
60. Lee SH, Kim KH, Kim JM et al. Relationship between group-specific component protein and the development of asthma. Am J Respir Crit Care Med 2011; 184:528-36.
61. Coyne CB, Vanhook MK, Gambling TM, Carson JL, Boucher RC, Johnson LG. Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell 2002; 13:3218-34.
62. Sajjan U, Wang Q, Zhao Y, Gruenert DC, Hershenson MB. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med 2008; 178: 1271-81.